MBX compared with ZBIO: revenue, margins and what each company keeps, and the suppliers and customers both name

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

ZBIOZenas BioPharma, Inc.

Mkt capRevenueRevenue

Compare

MBXMBX Biosciences, Inc.

ZBIOZenas BioPharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MBX 3

—Dr. Richard DiMarchiunlistedsupplier

—Indiana University Research and Technology Corporation ("IURTC")unlistedsupplier

—Trustees of Indiana Universityunlistedsupplier

Shared 0

No shared counterparties.

Only ZBIO 10

BMYBristol-Myers Squibbcustomer

XNCRXencorsupplier

—InnoCareunlistedsupplier

—WuXi Biologics

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

supplier

6 more · ZBIO chain ›

MBXMBX Biosciences, Inc.

51.17▲+5.59%· post 51.17

Mkt cap$2.4BRevenue—

ZBIOZenas BioPharma, Inc.

28.28▲+9.07%· post 28.28

ClosedNov 6 '26

Mkt cap$1.9BRevenue$10MQ3 FY26

Compare

ClosedNov 6 '26

MBXMBX Biosciences, Inc.

ZBIOZenas BioPharma, Inc.

51.17▲+5.59%post 51.17

Price

28.28▲+9.07%post 28.28

$2.4B

Mkt cap

$1.9B

—

Revenue

$10MQ3 FY26

MBX51.17▲+5.59%vsZBIO28.28▲+9.07%ClosedNov 6 '26